|
Global Biochip Markets: Microarrays and Lab-on-a-ChipPublished by: BCC Research Published: Sep. 1, 2007 Table of Contents
AbstractBiology is following a path that is reminiscent of the early electronics industry: a miniaturization and large-scale integration process that will revolutionize life science research, drug discovery and development, medical diagnostics and biotechnology. The ongoing miniaturization and large-scale integration process is encompassed in devices known as biochips, including microarrays and lab-on-a-chip microfluidic devices. Biochips represent a diverse group of nanotechnologies that can be expected to exert a significant impact in life science research, diagnostics and medicine.DNA microarrays are already an established technology generating substantial revenue derived from gene expression, SNP analysis and gene resequencing. The first DNA microarray has recently been approved by the FDA for in-vitro diagnostic applications, and significant market growth can be expected in this application area. Protein microarrays are gaining prominence in the marketplace, while future, emerging array technologies including tissue/cell and glycomics arrays are increasing in importance. Lab-on-chip devices are also making rapid progress in important pharmaceutical and diagnostics market segments. BCC previously examined the biochip industry in 2004. Given the rapidly advancing bio- and nano-technologies associated with this business, it is timely to re-examine the biochips business. Get Full Details About This Report >> |
|
|||
|
About MarketResearch.com
|
||||